Phosphorylation alters Bim‐mediated Mcl‐1 stabilization and priming
Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl‐2 proteins affect its regulation. One such protein, Bim, is know...
Saved in:
Published in | The FEBS journal Vol. 285; no. 14; pp. 2626 - 2640 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.07.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl‐2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl‐1, and Bim phosphorylation has been associated with increased Mcl‐1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl‐1 stability. We found that Bim stabilizes and primes Mcl‐1 in RPCI‐WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho‐mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl‐1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl‐1 stability but also is a potential mechanism for enforcing Mcl‐1 dependence.
Mcl‐1 is highly labile and frequently targeted for ubiquitination. Wild‐type Bim overexpression stabilized and preferentially primed Mcl‐1. Conversely, the introduction of several Bim phosphorylation site mutations resulted in the altered ability to stabilize Mcl‐1 and differential Bim binding to antiapoptotic proteins. Our findings suggest Bim phosphorylation influences Bcl‐2 family priming and dependence. |
---|---|
AbstractList | Mcl-1 is a highly labile protein, subject to extensive post-translational regulation. This distinguishes Mcl-1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl-2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl-1, and Bim phosphorylation has been associated with increased Mcl-1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl-1 stability. We found that Bim stabilizes and primes Mcl-1 in RPCI-WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho-mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl-1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl-1 stability but also is a potential mechanism for enforcing Mcl-1 dependence. Mcl-1 is a highly labile protein, subject to extensive posttranslational regulation. This distinguishes Mcl-1 from other anti-apoptotic proteins and necessitates further study to better understand how interactions with pro-apoptotic Bcl-2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl-1, and Bim phosphorylation has been associated with increased Mcl-1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl-1 stability. We found that Bim stabilizes and primes Mcl-1 in RPCI-WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho-mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl-1 stability and distinct Bim binding to anti-apoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl-1 stability but also is a potential mechanism for enforcing Mcl-1 dependence. Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl‐2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl‐1, and Bim phosphorylation has been associated with increased Mcl‐1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl‐1 stability. We found that Bim stabilizes and primes Mcl‐1 in RPCI‐WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho‐mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl‐1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl‐1 stability but also is a potential mechanism for enforcing Mcl‐1 dependence. Mcl‐1 is highly labile and frequently targeted for ubiquitination. Wild‐type Bim overexpression stabilized and preferentially primed Mcl‐1. Conversely, the introduction of several Bim phosphorylation site mutations resulted in the altered ability to stabilize Mcl‐1 and differential Bim binding to antiapoptotic proteins. Our findings suggest Bim phosphorylation influences Bcl‐2 family priming and dependence. Mcl-1 is a highly labile protein, subject to extensive post-translational regulation. This distinguishes Mcl-1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl-2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl-1, and Bim phosphorylation has been associated with increased Mcl-1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl-1 stability. We found that Bim stabilizes and primes Mcl-1 in RPCI-WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho-mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl-1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl-1 stability but also is a potential mechanism for enforcing Mcl-1 dependence.Mcl-1 is a highly labile protein, subject to extensive post-translational regulation. This distinguishes Mcl-1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl-2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl-1, and Bim phosphorylation has been associated with increased Mcl-1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl-1 stability. We found that Bim stabilizes and primes Mcl-1 in RPCI-WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho-mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl-1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl-1 stability but also is a potential mechanism for enforcing Mcl-1 dependence. Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl‐2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl‐1, and Bim phosphorylation has been associated with increased Mcl‐1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl‐1 stability. We found that Bim stabilizes and primes Mcl‐1 in RPCI ‐ WM 1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho‐mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl‐1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl‐1 stability but also is a potential mechanism for enforcing Mcl‐1 dependence. |
Author | Boise, Lawrence H. Conage‐Pough, Jason E. |
AuthorAffiliation | 2 Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 1 Cancer Biology Graduate Program |
AuthorAffiliation_xml | – name: 2 Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA – name: 1 Cancer Biology Graduate Program |
Author_xml | – sequence: 1 givenname: Jason E. surname: Conage‐Pough fullname: Conage‐Pough, Jason E. organization: Emory University – sequence: 2 givenname: Lawrence H. surname: Boise fullname: Boise, Lawrence H. email: lboise@emory.edu organization: Emory University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29775995$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkd1qVDEUhYNUbDt64wPIAW9EmJr_nNwItrRVqCio4F3IyU8nJZOMyRlletVH8Bl9EjOdcdAimpsk5Ntrr-x1CPZSTg6AxwgeobZeeDfUI0QZZPfAARIUTyln_d7uTD_vg8NaryAkjEr5AOxjKQSTkh2A8_ezXBezXFZRjyGnTsfRldodh_mPm-9zZ4Mene3emtiuqKujHkIM11s22W5Rwjyky4fgvtexukfbfQI-nZ1-PHk9vXh3_ubk1cXUMCrYFCOHHRmMlnognAjiqcHcEmGtFc5w6HqEpbe90dRDRr32etA9ZFZ6wXVPJuDlRnexHJo749JYdFRrF7qsVNZB_fmSwkxd5q-KY8REm8AEPNsKlPxl6eqo5qEaF6NOLi-rwggiQnvJ-f9RSBGnkBLZ0Kd30Ku8LKlNolGCtN5Y0kY9-d38zvWvOBrwfAOYkmstzu8QBNU6a7XOWt1m3WB4BzZhvA2mfTzEv5egTcm3EN3qH-Lq7PT4w6bmJ3LyvmA |
CitedBy_id | crossref_primary_10_1182_blood_2019004326 crossref_primary_10_1038_s41419_022_05214_9 crossref_primary_10_1186_s13045_021_01079_1 crossref_primary_10_2174_1389203724666230822100131 crossref_primary_10_3389_fphar_2022_1032069 crossref_primary_10_3390_cells10030559 crossref_primary_10_1182_blood_2024024341 crossref_primary_10_1007_s10753_020_01240_x crossref_primary_10_1038_s41467_024_50063_z crossref_primary_10_1182_blood_2018_07_864207 crossref_primary_10_3389_fonc_2020_625199 crossref_primary_10_1016_j_clml_2022_07_013 crossref_primary_10_3389_fonc_2022_899272 crossref_primary_10_1016_j_compbiolchem_2025_108427 crossref_primary_10_1016_j_xcrm_2023_101007 crossref_primary_10_3389_fonc_2022_1005659 crossref_primary_10_7554_eLife_54954 crossref_primary_10_1016_j_xcrm_2023_101178 |
Cites_doi | 10.1038/onc.2015.103 10.1016/j.febslet.2005.09.028 10.1038/cdd.2013.114 10.1073/pnas.0701297104 10.1074/jbc.M301010200 10.1038/nrm2952 10.1074/mcp.T600044-MCP200 10.18632/oncotarget.10847 10.1016/j.molcel.2004.12.030 10.1053/j.gastro.2008.12.064 10.1016/S1097-2765(01)00214-3 10.1073/pnas.0438011100 10.1016/S1097-2765(00)80456-6 10.1038/cddis.2014.561 10.1016/S1535-6108(02)00127-7 10.1038/nm.3048 10.1126/science.1092734 10.1093/carcin/bgp165 10.1038/ni.2527 10.1126/science.1106114 10.1016/1074-7613(95)90161-2 10.1074/jbc.M610010200 10.1016/j.bbrc.2007.07.070 10.1038/cdd.2013.78 10.1242/jcs.135137 10.3390/cells3020418 10.1002/1873-3468.12497 10.1038/nature08822 10.3109/10428194.2012.713481 10.1016/j.febslet.2010.05.061 10.1128/MCB.00620-06 10.1038/nchembio.2174 10.1074/jbc.M505546200 10.18632/oncotarget.20222 10.1016/j.molcel.2008.12.020 10.1038/cdd.2013.93 10.1074/jbc.M411434200 10.18632/oncotarget.9217 10.1182/blood-2004-10-3984 10.1016/j.bbamcr.2003.08.012 10.1016/j.molcel.2010.01.025 10.1016/j.exer.2016.08.002 10.1038/nature03579 10.1038/nature19830 10.1073/pnas.90.8.3516 10.1182/blood-2011-01-327197 10.1056/NEJMoa1513257 10.1101/gad.14.16.2060 10.1080/15384047.2014.1002333 10.1038/cdd.2011.198 10.1038/cdd.2014.209 10.1016/j.molcel.2012.05.040 10.1038/sj.cdd.4400783 10.1016/j.bbrc.2011.08.118 10.1186/s12885-017-3442-y 10.1016/0092-8674(92)90123-T 10.1073/pnas.0406837101 10.1016/j.molcel.2005.02.003 10.1038/cddis.2016.237 10.1038/nrd.2016.253 10.1016/j.molcel.2008.03.025 10.1158/0008-5472.CAN-07-5836 10.1038/leu.2015.350 10.1074/mcp.M700574-MCP200 10.1016/j.celrep.2014.07.057 10.1101/gad.1093903 10.1038/nature02067 10.1083/jcb.200904049 10.1038/sj.onc.1208873 10.1074/jbc.M114.569376 10.1038/sj.onc.1206792 10.1073/pnas.91.20.9238 10.1038/sj.emboj.7601723 10.1182/blood-2016-10-745059 10.1038/cdd.2013.79 10.1182/blood-2007-10-116889 |
ContentType | Journal Article |
Copyright | 2018 Federation of European Biochemical Societies 2018 Federation of European Biochemical Societies. Copyright © 2018 Federation of European Biochemical Societies |
Copyright_xml | – notice: 2018 Federation of European Biochemical Societies – notice: 2018 Federation of European Biochemical Societies. – notice: Copyright © 2018 Federation of European Biochemical Societies |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7TK 7TM 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 7S9 L.6 5PM |
DOI | 10.1111/febs.14505 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Nucleic Acids Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Genetics Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE Virology and AIDS Abstracts AGRICOLA MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1742-4658 |
EndPage | 2640 |
ExternalDocumentID | PMC6215700 29775995 10_1111_febs_14505 FEBS14505 |
Genre | article Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: UNCF‐Merck Foundation – fundername: National Cancer Institute funderid: R01 CA192844 – fundername: NCI NIH HHS grantid: R01 CA192844 |
GroupedDBID | --- -DZ -~X .3N .55 .GA .Y3 05W 0R~ 10A 1OC 24P 29H 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHBH AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEFU ABEML ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFS ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACSCC ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C1A C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EAD EAP EAS EAU EBB EBC EBD EBS EBX EJD EMB EMK EMOBN EST ESX EX3 F00 F01 F04 F5P FIJ FUBAC G-S G.N GODZA GX1 H.X HF~ HGLYW HH5 HZI HZ~ IHE IX1 J0M KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OBS OIG OK1 OVD P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K RNS ROL RX1 SUPJJ SV3 TEORI TR2 TUS UB1 V8K W8V W99 WBFHL WBKPD WIH WIJ WIK WIN WOHZO WOQ WOW WQJ WRC WXI WXSBR WYISQ X7M XG1 Y6R ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGYGG CITATION CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7TK 7TM 7U9 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY C1K FR3 H94 M7N P64 RC3 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c5475-21e2e3bca9ab36373f4c26d37ddd7ec60e8129fd8ca4f054fafaba805d9f76a83 |
IEDL.DBID | DR2 |
ISSN | 1742-464X 1742-4658 |
IngestDate | Thu Aug 21 18:42:34 EDT 2025 Fri Jul 11 18:38:25 EDT 2025 Fri Jul 11 15:11:54 EDT 2025 Fri Jul 25 19:36:56 EDT 2025 Thu Apr 03 07:02:47 EDT 2025 Thu Apr 24 23:11:50 EDT 2025 Tue Jul 01 03:06:48 EDT 2025 Wed Jan 22 16:20:51 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 14 |
Keywords | priming Bim phosphorylation Mcl-1 stability |
Language | English |
License | 2018 Federation of European Biochemical Societies. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5475-21e2e3bca9ab36373f4c26d37ddd7ec60e8129fd8ca4f054fafaba805d9f76a83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Author Contributions JEC-P and LHB conceived the study, designed the experiments, and wrote and revised the manuscript. JEC-P performed the experiments and LHB supervised the study. |
OpenAccessLink | https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.14505 |
PMID | 29775995 |
PQID | 2073215294 |
PQPubID | 28478 |
PageCount | 15 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6215700 proquest_miscellaneous_2101348966 proquest_miscellaneous_2041640439 proquest_journals_2073215294 pubmed_primary_29775995 crossref_primary_10_1111_febs_14505 crossref_citationtrail_10_1111_febs_14505 wiley_primary_10_1111_febs_14505_FEBS14505 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2018 |
PublicationDateYYYYMMDD | 2018-07-01 |
PublicationDate_xml | – month: 07 year: 2018 text: July 2018 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | The FEBS journal |
PublicationTitleAlternate | FEBS J |
PublicationYear | 2018 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2010; 11 2007; 104 2017; 8 2011; 118 2013; 20 2000; 7 2005; 579 2010; 584 2010; 463 2008; 7 2016; 30 2012; 19 2003; 17 2017; 591 2008; 30 2003; 278 2016; 35 2005; 24 2013; 19 2014; 127 2013; 14 2014; 3 2000; 14 2013; 54 2005; 105 2005; 307 2007; 6 2008; 68 2006; 281 2014; 8 2008; 111 1996; 2 2016; 151 2007; 26 2014; 289 2007; 27 2017; 129 2011; 413 2004; 101 2004; 303 2015; 6 2010; 37 2015; 16 2007; 282 2007; 361 2005; 435 2002; 2 1993; 90 1999; 3 1995; 3 2009; 136 2004; 1644 2016; 12 2009; 33 2005; 280 2016; 7 2009; 30 2003; 426 2001; 7 2016; 538 2017; 17 2017; 16 2015; 22 2009; 187 2016; 374 1992; 69 2012; 47 1994; 91 2005; 17 2003; 100 2003; 22 e_1_2_9_75_1 e_1_2_9_31_1 e_1_2_9_52_1 e_1_2_9_50_1 e_1_2_9_73_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_56_1 e_1_2_9_77_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_54_1 e_1_2_9_71_1 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_58_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_64_1 e_1_2_9_62_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_68_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_66_1 e_1_2_9_8_1 e_1_2_9_6_1 e_1_2_9_4_1 e_1_2_9_60_1 e_1_2_9_2_1 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_28_1 e_1_2_9_47_1 e_1_2_9_30_1 e_1_2_9_53_1 e_1_2_9_74_1 e_1_2_9_51_1 e_1_2_9_72_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_78_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_55_1 e_1_2_9_76_1 e_1_2_9_70_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_19_1 Kumar R (e_1_2_9_20_1) 1996; 2 e_1_2_9_42_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_61_1 e_1_2_9_21_1 e_1_2_9_46_1 e_1_2_9_67_1 e_1_2_9_23_1 e_1_2_9_44_1 e_1_2_9_65_1 e_1_2_9_7_1 e_1_2_9_5_1 e_1_2_9_3_1 e_1_2_9_9_1 e_1_2_9_25_1 e_1_2_9_27_1 e_1_2_9_48_1 e_1_2_9_69_1 e_1_2_9_29_1 |
References_xml | – volume: 7 start-page: 1598 year: 2008 end-page: 1608 article-title: GPS 2.0, a tool to predict kinase‐specific phosphorylation sites in hierarchy publication-title: Mol Cell Proteomics – volume: 2 start-page: 1215 year: 1996 end-page: 1219 article-title: Overexpression of HER2 modulates bcl‐2, bcl‐XL, and tamoxifen‐induced apoptosis in human MCF‐7 breast cancer cells publication-title: Clin Cancer Res – volume: 280 start-page: 4738 year: 2005 end-page: 4744 article-title: Solution structure of prosurvival Mcl‐1 and characterization of its binding by proapoptotic BH3‐only ligands publication-title: J Biol Chem – volume: 435 start-page: 677 year: 2005 end-page: 681 article-title: An inhibitor of Bcl‐2 family proteins induces regression of solid tumours publication-title: Nature – volume: 2 start-page: 183 year: 2002 end-page: 192 article-title: Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics publication-title: Cancer Cell – volume: 281 start-page: 813 year: 2006 end-page: 823 article-title: Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function publication-title: J Biol Chem – volume: 278 start-page: 18811 year: 2003 end-page: 18816 article-title: Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome‐dependent degradation of the BH3‐only protein, Bim publication-title: J Biol Chem – volume: 289 start-page: 23629 year: 2014 end-page: 23640 article-title: Bcl‐xL protein protects from C/EBP homologous protein (CHOP)‐dependent apoptosis during plasma cell differentiation publication-title: J Biol Chem – volume: 14 start-page: 290 year: 2013 end-page: 297 article-title: Mcl‐1 is essential for the survival of plasma cells publication-title: Nat Immunol – volume: 20 start-page: 1317 year: 2013 end-page: 1329 article-title: Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK publication-title: Cell Death Differ – volume: 20 start-page: 1475 year: 2013 end-page: 1484 article-title: Evaluation and critical assessment of putative MCL‐1 inhibitors publication-title: Cell Death Differ – volume: 463 start-page: 899 year: 2010 end-page: 905 article-title: The landscape of somatic copy‐number alteration across human cancers publication-title: Nature – volume: 538 start-page: 477 year: 2016 end-page: 482 article-title: The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models publication-title: Nature – volume: 19 start-page: 202 year: 2013 end-page: 208 article-title: ABT‐199, a potent and selective BCL‐2 inhibitor, achieves antitumor activity while sparing platelets publication-title: Nat Med – volume: 30 start-page: 1086 year: 2016 end-page: 1093 article-title: Dexamethasone treatment promotes Bcl‐2 dependence in multiple myeloma resulting in sensitivity to venetoclax publication-title: Leukemia – volume: 7 start-page: 36353 year: 2016 end-page: 36365 article-title: DNA damaging agent‐induced apoptosis is regulated by MCL‐1 phosphorylation and degradation mediated by the Noxa/MCL‐1/CDK2 complex publication-title: Oncotarget – volume: 7 start-page: 59727 year: 2016 end-page: 59741 article-title: Bortezomib‐induced heat shock response protects multiple myeloma cells and is activated by heat shock factor 1 serine 326 phosphorylation publication-title: Oncotarget – volume: 24 start-page: 7224 year: 2005 end-page: 7237 article-title: Puma(*)Mcl‐1 interaction is not sufficient to prevent rapid degradation of Mcl‐1 publication-title: Oncogene – volume: 14 start-page: 2060 year: 2000 end-page: 2071 article-title: tBID, a membrane‐targeted death ligand, oligomerizes BAK to release cytochrome c publication-title: Genes Dev – volume: 54 start-page: 387 year: 2013 end-page: 396 article-title: Development and characterization of a novel human Waldenstrom macroglobulinemia cell line: RPCI‐WM1, Roswell Park Cancer Institute ‐ Waldenstrom Macroglobulinemia 1 publication-title: Leuk Lymphoma – volume: 136 start-page: 1423 year: 2009 end-page: 1434 article-title: Antiapoptotic effect of c‐Jun N‐terminal Kinase‐1 through Mcl‐1 stabilization in TNF‐induced hepatocyte apoptosis publication-title: Gastroenterology – volume: 17 start-page: 525 year: 2005 end-page: 535 article-title: BH3 domains of BH3‐only proteins differentially regulate Bax‐mediated mitochondrial membrane permeabilization both directly and indirectly publication-title: Mol Cell – volume: 8 start-page: 1347 year: 2014 end-page: 1353 article-title: BIM is the primary mediator of MYC‐induced apoptosis in multiple solid tissues publication-title: Cell Rep – volume: 127 start-page: 2217 year: 2014 end-page: 2226 article-title: Procaspase‐3 regulates fibronectin secretion and influences adhesion, migration and survival independently of catalytic function publication-title: J Cell Sci – volume: 17 start-page: 449 year: 2017 article-title: Targeting MCL‐1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin‐induced apoptosis publication-title: BMC Cancer – volume: 22 start-page: 1275 year: 2015 end-page: 1286 article-title: Anoikis evasion in inflammatory breast cancer cells is mediated by Bim‐EL sequestration publication-title: Cell Death Differ – volume: 413 start-page: 460 year: 2011 end-page: 464 article-title: Noxa controls Mule‐dependent Mcl‐1 ubiquitination through the regulation of the Mcl‐1/USP9X interaction publication-title: Biochem Biophys Res Commun – volume: 303 start-page: 1010 year: 2004 end-page: 1014 article-title: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis publication-title: Science – volume: 19 start-page: 1060 year: 2012 end-page: 1068 article-title: Alternative splicing of Bim and Erk‐mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis publication-title: Cell Death Differ – volume: 307 start-page: 1101 year: 2005 end-page: 1104 article-title: Obligate role of anti‐apoptotic MCL‐1 in the survival of hematopoietic stem cells publication-title: Science – volume: 104 start-page: 6217 year: 2007 end-page: 6222 article-title: Structural insights into the degradation of Mcl‐1 induced by BH3 domains publication-title: Proc Natl Acad Sci USA – volume: 33 start-page: 109 year: 2009 end-page: 116 article-title: betaTrCP‐ and Rsk1/2‐mediated degradation of BimEL inhibits apoptosis publication-title: Mol Cell – volume: 20 start-page: 1393 year: 2013 end-page: 1403 article-title: BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by betaTrCP1 publication-title: Cell Death Differ – volume: 426 start-page: 671 year: 2003 end-page: 676 article-title: Development and maintenance of B and T lymphocytes requires antiapoptotic MCL‐1 publication-title: Nature – volume: 22 start-page: 6785 year: 2003 end-page: 6793 article-title: Phosphorylation of Bim‐EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function publication-title: Oncogene – volume: 1644 start-page: 83 year: 2004 end-page: 94 article-title: Structural biology of the Bcl‐2 family of proteins publication-title: Biochim Biophys Acta – volume: 37 start-page: 299 year: 2010 end-page: 310 article-title: The BCL‐2 family reunion publication-title: Mol Cell – volume: 69 start-page: 119 year: 1992 end-page: 128 article-title: Induction of apoptosis in fibroblasts by c‐myc protein publication-title: Cell – volume: 101 start-page: 15313 year: 2004 end-page: 15317 article-title: Survival factor‐induced extracellular signal‐regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity publication-title: Proc Natl Acad Sci USA – volume: 361 start-page: 865 year: 2007 end-page: 869 article-title: Reciprocal protection of Mcl‐1 and Bim from ubiquitin‐proteasome degradation publication-title: Biochem Biophys Res Commun – volume: 12 start-page: 931 year: 2016 end-page: 936 article-title: Inhibition of Mcl‐1 through covalent modification of a noncatalytic lysine side chain publication-title: Nat Chem Biol – volume: 35 start-page: 479 year: 2016 end-page: 490 article-title: Low expression of pro‐apoptotic Bcl‐2 family proteins sets the apoptotic threshold in Waldenstrom macroglobulinemia publication-title: Oncogene – volume: 105 start-page: 3255 year: 2005 end-page: 3262 article-title: Evidence for a protective role of Mcl‐1 in proteasome inhibitor‐induced apoptosis publication-title: Blood – volume: 17 start-page: 1475 year: 2003 end-page: 1486 article-title: Elimination of Mcl‐1 is required for the initiation of apoptosis following ultraviolet irradiation publication-title: Genes Dev – volume: 7 start-page: 683 year: 2001 end-page: 694 article-title: PUMA, a novel proapoptotic gene, is induced by p53 publication-title: Mol Cell – volume: 584 start-page: 2981 year: 2010 end-page: 2989 article-title: Mcl‐1; the molecular regulation of protein function publication-title: FEBS Lett – volume: 16 start-page: 273 year: 2017 end-page: 284 article-title: From basic apoptosis discoveries to advanced selective BCL‐2 family inhibitors publication-title: Nat Rev Drug Discov – volume: 591 start-page: 240 year: 2017 end-page: 251 article-title: Discovery and biological characterization of potent myeloid cell leukemia‐1 inhibitors publication-title: FEBS Lett – volume: 91 start-page: 9238 year: 1994 end-page: 9242 article-title: Interactions among members of the Bcl‐2 protein family analyzed with a yeast two‐hybrid system publication-title: Proc Natl Acad Sci USA – volume: 7 start-page: 1166 year: 2000 end-page: 1173 article-title: Pro‐apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c publication-title: Cell Death Differ – volume: 17 start-page: 393 year: 2005 end-page: 403 article-title: Differential targeting of prosurvival Bcl‐2 proteins by their BH3‐only ligands allows complementary apoptotic function publication-title: Mol Cell – volume: 90 start-page: 3516 year: 1993 end-page: 3520 article-title: MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2 publication-title: Proc Natl Acad Sci USA – volume: 47 start-page: 359 year: 2012 end-page: 370 article-title: Bim inhibits autophagy by recruiting Beclin 1 to microtubules publication-title: Mol Cell – volume: 26 start-page: 2856 year: 2007 end-page: 2867 article-title: ERK1/2‐dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl‐1 and Bcl‐xL publication-title: EMBO J – volume: 68 start-page: 3421 year: 2008 end-page: 3428 article-title: ABT‐263: a potent and orally bioavailable Bcl‐2 family inhibitor publication-title: Cancer Res – volume: 20 start-page: 1440 year: 2013 end-page: 1441 article-title: Seeking a MCL‐1 inhibitor publication-title: Cell Death Differ – volume: 579 start-page: 5603 year: 2005 end-page: 5608 article-title: BH3‐ligand regulates access of MCL‐1 to its E3 ligase publication-title: FEBS Lett – volume: 3 start-page: 418 year: 2014 end-page: 437 article-title: Mcl‐1 ubiquitination: unique regulation of an essential survival protein publication-title: Cells – volume: 27 start-page: 4006 year: 2007 end-page: 4017 article-title: Degradation of Mcl‐1 by beta‐TrCP mediates glycogen synthase kinase 3‐induced tumor suppression and chemosensitization publication-title: Mol Cell Biol – volume: 16 start-page: 276 year: 2015 end-page: 286 article-title: EGFR signaling defines Mcl(‐)1 survival dependency in neuroblastoma publication-title: Cancer Biol Ther – volume: 6 start-page: 356 year: 2007 end-page: 366 article-title: Label‐free kinase profiling using phosphate affinity polyacrylamide gel electrophoresis publication-title: Mol Cell Proteomics – volume: 129 start-page: 1969 year: 2017 end-page: 1979 article-title: Bone marrow microenvironment‐derived signals induce Mcl‐1 dependence in multiple myeloma publication-title: Blood – volume: 282 start-page: 18407 year: 2007 end-page: 18417 article-title: Serine 64 phosphorylation enhances the antiapoptotic function of Mcl‐1 publication-title: J Biol Chem – volume: 187 start-page: 429 year: 2009 end-page: 442 article-title: MCL‐1‐dependent leukemia cells are more sensitive to chemotherapy than BCL‐2‐dependent counterparts publication-title: J Cell Biol – volume: 100 start-page: 2432 year: 2003 end-page: 2437 article-title: JNK phosphorylation of Bim‐related members of the Bcl2 family induces Bax‐dependent apoptosis publication-title: Proc Natl Acad Sci USA – volume: 3 start-page: 87 year: 1995 end-page: 98 article-title: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl‐XL publication-title: Immunity – volume: 7 start-page: e2345 year: 2016 article-title: MCL‐1 is required throughout B‐cell development and its loss sensitizes specific B‐cell subsets to inhibition of BCL‐2 or BCL‐XL publication-title: Cell Death Dis – volume: 6 start-page: e1590 year: 2015 article-title: Potent and selective small‐molecule MCL‐1 inhibitors demonstrate on‐target cancer cell killing activity as single agents and in combination with ABT‐263 (navitoclax) publication-title: Cell Death Dis – volume: 118 start-page: 1329 year: 2011 end-page: 1339 article-title: Distribution of Bim determines Mcl‐1 dependence or codependence with Bcl‐xL/Bcl‐2 in Mcl‐1‐expressing myeloma cells publication-title: Blood – volume: 11 start-page: 621 year: 2010 end-page: 632 article-title: Mitochondria and cell death: outer membrane permeabilization and beyond publication-title: Nat Rev Mol Cell Biol – volume: 30 start-page: 1517 year: 2009 end-page: 1527 article-title: Cisplatin overcomes Bcl‐2‐mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa‐mediated lipid peroxidation publication-title: Carcinogenesis – volume: 30 start-page: 415 year: 2008 end-page: 425 article-title: Multisite phosphorylation regulates Bim stability and apoptotic activity publication-title: Mol Cell – volume: 374 start-page: 311 year: 2016 end-page: 322 article-title: Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia publication-title: N Engl J Med – volume: 151 start-page: 82 year: 2016 end-page: 95 article-title: Insulin‐like growth factor 1 rescues R28 retinal neurons from apoptotic death through ERK‐mediated BimEL phosphorylation independent of Akt publication-title: Exp Eye Res – volume: 3 start-page: 287 year: 1999 end-page: 296 article-title: The proapoptotic activity of the Bcl‐2 family member Bim is regulated by interaction with the dynein motor complex publication-title: Mol Cell – volume: 8 start-page: 82981 year: 2017 end-page: 82990 article-title: Mcl‐1 stabilization confers resistance to taxol in human gastric cancer publication-title: Oncotarget – volume: 111 start-page: 5152 year: 2008 end-page: 5162 article-title: BH3‐only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide‐induced cell death in myeloma publication-title: Blood – ident: e_1_2_9_39_1 doi: 10.1038/onc.2015.103 – ident: e_1_2_9_31_1 doi: 10.1016/j.febslet.2005.09.028 – ident: e_1_2_9_69_1 doi: 10.1038/cdd.2013.114 – volume: 2 start-page: 1215 year: 1996 ident: e_1_2_9_20_1 article-title: Overexpression of HER2 modulates bcl‐2, bcl‐XL, and tamoxifen‐induced apoptosis in human MCF‐7 breast cancer cells publication-title: Clin Cancer Res – ident: e_1_2_9_29_1 doi: 10.1073/pnas.0701297104 – ident: e_1_2_9_36_1 doi: 10.1074/jbc.M301010200 – ident: e_1_2_9_8_1 doi: 10.1038/nrm2952 – ident: e_1_2_9_76_1 doi: 10.1074/mcp.T600044-MCP200 – ident: e_1_2_9_40_1 doi: 10.18632/oncotarget.10847 – ident: e_1_2_9_11_1 doi: 10.1016/j.molcel.2004.12.030 – ident: e_1_2_9_24_1 doi: 10.1053/j.gastro.2008.12.064 – ident: e_1_2_9_52_1 doi: 10.1016/S1097-2765(01)00214-3 – ident: e_1_2_9_32_1 doi: 10.1073/pnas.0438011100 – ident: e_1_2_9_59_1 doi: 10.1016/S1097-2765(00)80456-6 – ident: e_1_2_9_66_1 doi: 10.1038/cddis.2014.561 – ident: e_1_2_9_6_1 doi: 10.1016/S1535-6108(02)00127-7 – ident: e_1_2_9_67_1 doi: 10.1038/nm.3048 – ident: e_1_2_9_3_1 doi: 10.1126/science.1092734 – ident: e_1_2_9_18_1 doi: 10.1093/carcin/bgp165 – ident: e_1_2_9_12_1 doi: 10.1038/ni.2527 – ident: e_1_2_9_14_1 doi: 10.1126/science.1106114 – ident: e_1_2_9_77_1 doi: 10.1016/1074-7613(95)90161-2 – ident: e_1_2_9_23_1 doi: 10.1074/jbc.M610010200 – ident: e_1_2_9_28_1 doi: 10.1016/j.bbrc.2007.07.070 – ident: e_1_2_9_44_1 doi: 10.1038/cdd.2013.78 – ident: e_1_2_9_75_1 doi: 10.1242/jcs.135137 – ident: e_1_2_9_49_1 doi: 10.3390/cells3020418 – ident: e_1_2_9_65_1 doi: 10.1002/1873-3468.12497 – ident: e_1_2_9_72_1 doi: 10.1038/nature08822 – ident: e_1_2_9_73_1 doi: 10.3109/10428194.2012.713481 – ident: e_1_2_9_21_1 doi: 10.1016/j.febslet.2010.05.061 – ident: e_1_2_9_25_1 doi: 10.1128/MCB.00620-06 – ident: e_1_2_9_71_1 doi: 10.1038/nchembio.2174 – ident: e_1_2_9_43_1 doi: 10.1074/jbc.M505546200 – ident: e_1_2_9_17_1 doi: 10.18632/oncotarget.20222 – ident: e_1_2_9_35_1 doi: 10.1016/j.molcel.2008.12.020 – ident: e_1_2_9_34_1 doi: 10.1038/cdd.2013.93 – ident: e_1_2_9_10_1 doi: 10.1074/jbc.M411434200 – ident: e_1_2_9_26_1 doi: 10.18632/oncotarget.9217 – ident: e_1_2_9_48_1 doi: 10.1182/blood-2004-10-3984 – ident: e_1_2_9_60_1 doi: 10.1016/j.bbamcr.2003.08.012 – ident: e_1_2_9_2_1 doi: 10.1016/j.molcel.2010.01.025 – ident: e_1_2_9_33_1 doi: 10.1016/j.exer.2016.08.002 – ident: e_1_2_9_63_1 doi: 10.1038/nature03579 – ident: e_1_2_9_46_1 doi: 10.1038/nature19830 – ident: e_1_2_9_22_1 doi: 10.1073/pnas.90.8.3516 – ident: e_1_2_9_53_1 doi: 10.1182/blood-2011-01-327197 – ident: e_1_2_9_68_1 doi: 10.1056/NEJMoa1513257 – ident: e_1_2_9_7_1 doi: 10.1101/gad.14.16.2060 – ident: e_1_2_9_55_1 doi: 10.1080/15384047.2014.1002333 – ident: e_1_2_9_61_1 doi: 10.1038/cdd.2011.198 – ident: e_1_2_9_42_1 doi: 10.1038/cdd.2014.209 – ident: e_1_2_9_58_1 doi: 10.1016/j.molcel.2012.05.040 – ident: e_1_2_9_4_1 doi: 10.1038/sj.cdd.4400783 – ident: e_1_2_9_30_1 doi: 10.1016/j.bbrc.2011.08.118 – ident: e_1_2_9_19_1 doi: 10.1186/s12885-017-3442-y – ident: e_1_2_9_50_1 doi: 10.1016/0092-8674(92)90123-T – ident: e_1_2_9_37_1 doi: 10.1073/pnas.0406837101 – ident: e_1_2_9_5_1 doi: 10.1016/j.molcel.2005.02.003 – ident: e_1_2_9_13_1 doi: 10.1038/cddis.2016.237 – ident: e_1_2_9_62_1 doi: 10.1038/nrd.2016.253 – ident: e_1_2_9_45_1 doi: 10.1016/j.molcel.2008.03.025 – ident: e_1_2_9_64_1 doi: 10.1158/0008-5472.CAN-07-5836 – ident: e_1_2_9_78_1 doi: 10.1038/leu.2015.350 – ident: e_1_2_9_41_1 doi: 10.1074/mcp.M700574-MCP200 – ident: e_1_2_9_51_1 doi: 10.1016/j.celrep.2014.07.057 – ident: e_1_2_9_47_1 doi: 10.1101/gad.1093903 – ident: e_1_2_9_15_1 doi: 10.1038/nature02067 – ident: e_1_2_9_54_1 doi: 10.1083/jcb.200904049 – ident: e_1_2_9_27_1 doi: 10.1038/sj.onc.1208873 – ident: e_1_2_9_16_1 doi: 10.1074/jbc.M114.569376 – ident: e_1_2_9_57_1 doi: 10.1038/sj.onc.1206792 – ident: e_1_2_9_9_1 doi: 10.1073/pnas.91.20.9238 – ident: e_1_2_9_56_1 doi: 10.1038/sj.emboj.7601723 – ident: e_1_2_9_38_1 doi: 10.1182/blood-2016-10-745059 – ident: e_1_2_9_70_1 doi: 10.1038/cdd.2013.79 – ident: e_1_2_9_74_1 doi: 10.1182/blood-2007-10-116889 |
SSID | ssj0035499 |
Score | 2.3657148 |
Snippet | Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and... Mcl-1 is a highly labile protein, subject to extensive post-translational regulation. This distinguishes Mcl-1 from other antiapoptotic proteins and... Mcl-1 is a highly labile protein, subject to extensive posttranslational regulation. This distinguishes Mcl-1 from other anti-apoptotic proteins and... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2626 |
SubjectTerms | Antineoplastic Agents - pharmacology Apoptosis Apoptosis - drug effects Apoptosis - genetics Bcl-2-Like Protein 11 - genetics Bcl-2-Like Protein 11 - metabolism bcl-X Protein - genetics bcl-X Protein - metabolism Bim phosphorylation Binding Bortezomib - pharmacology Cell Line, Tumor Dependence Gene Expression Regulation, Neoplastic HEK293 Cells Humans Mcl‐1 stability Mutation Myeloid Cell Leukemia Sequence 1 Protein - genetics Myeloid Cell Leukemia Sequence 1 Protein - metabolism Myeloid Cells - drug effects Myeloid Cells - metabolism Myeloid Cells - pathology Phosphorylation Phosphorylation - drug effects Plasma Cells - drug effects Plasma Cells - metabolism Plasma Cells - pathology Priming Protein Binding Protein Processing, Post-Translational Protein Stability Proteins Proto-Oncogene Proteins c-bcl-2 - genetics Proto-Oncogene Proteins c-bcl-2 - metabolism Signal Transduction Stability |
Title | Phosphorylation alters Bim‐mediated Mcl‐1 stabilization and priming |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ffebs.14505 https://www.ncbi.nlm.nih.gov/pubmed/29775995 https://www.proquest.com/docview/2073215294 https://www.proquest.com/docview/2041640439 https://www.proquest.com/docview/2101348966 https://pubmed.ncbi.nlm.nih.gov/PMC6215700 |
Volume | 285 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD6U-qAvXlq10VpGFEEhJclkZhLoy27btQgVUQv7ImFucYttdml2H9onf4K_0V_SM5NLu1YK-paQE5jLOTPfzHzzHYDX3MZM0kiGihmBCxRpQilyHSboHNqanGuv0334kR8cpR_GbLwCO91dmEYfot9wc5Hhx2sX4FLV14K8tKrGOGdewNSRtRwi-txrR1G38GluQyZhytNxq03qaDxXvy7PRjcg5k2m5HUE66eg0QP41hW-YZ782F7M1ba--EPX8X9r9xDut9iUDBpnegQrtlqD9UGF6_LTc_KGeLao34Zfg7u7Xaa4dXj_aTKtZ5Pp2XlDrCP-CL4mw-PT3z9_-bspiGvJoT7B15ggHnWM3IvWtjJk5nOLfX8MR6P9r7sHYZugIdQsFSxMYptYqrTMpaKcClqmOuGGCmOMsJpHFuFDXppMy7REbFjKUiqZRczkpeAyo09gtZpWdgNIFpeJ1ArhCJWp9pI4jDGZ6SiWLMtVAG-7jip0q17ukmicFN0qxrVY4VssgFe97azR7Pir1WbX30Ubt3WR4IjnMv3maQAv-8_YnO4YRVZ2unA2CGKdKFF-iw2OdBQrwXkATxsX6ouSIOR2Mm8BiCXn6g2c4vfyl-p44pW_OZZNRFEA77zv3FK7YrQ__OKfnv2L8XO4h12QNXzkTVidny3sC0Rdc7UFdwbDveFoy0fZJcOqLaI |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL0qZVE2BVoegQJGPCSQUiVO7CQLFn0NU9qpELTS7IJjO52KNhl1ZoSmKz6BH-FX-Ai-hGvnQYeiSiy6YJcoV5Ef99rnJsfnAjzn2mci8ISbMRVhgiKUK6JEuhSdQ2qVcGl1unt7vHsQvuuz_hx8b87CVPoQ7Qc3Exl2vTYBbj5In4vyXGcjDHTcwmtO5Y6efsGMbfRmexOn9wWlna39ja5bFxVwJQsj5lJfUx1kUiQiC3gQBXkoKVdBpJSKtOSexi0vyVUsRZgjnslFLjIRe0wlecRFHOB7r8F1U0LcSPVvfmjVqgKTalXnL6kb8rBfq6Ea4tDvts7ufxdA7UVu5nnMbDe9zk340QxXxXX5vDoZZ6vy7A8lyf9mPG_BYg2_yVoVL7dhThdLsLxWiHF5MiUviSXE2j8NS7Cw0RTDW4a37wflaDgoT6cVd5BYlsGIrB-d_Pz6zR6_QehOevIYb32CkNuQjs9q20KRoS2fdngHDq6ke3dhvigLfR9I7OdUyAwRVyBCaVV_GGMilp4vWJxkDrxqPCOVtUC7qRNynDaJmpmh1M6QA89a22ElS_JXq5XGwdJ6aRqlFBd1U8w4CR142j7G4TR_ikShy4mxQZxudJeSS2xwMQ-wE5w7cK_y2bYpFLMKo2TnQDTjza2BETWffVIcDay4Oce2RZ7nwGvrrJf0Lu1srX-0Vw_-xfgJLHT3e7vp7vbezkO4gdMRV_TrFZgfn070IwSZ4-yxDW0Cn67a938BQmqM4g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL0qRQI2PFoegQJGPCSQUiV24iQLFm2nQ0tpVUErzS44tsNUtMmomRGarvgEPoRf4Sf4Eq6dBx2KKrHogl2iXEV-3GufmxyfC_CMaz8UzBNuFqoIExShXBEl0qXoHFKrhEur0729wzf2g7eDcDAH39uzMLU-RPfBzUSGXa9NgI9UfirIc51VGOe4gzeUyi09_YIJW_V6s4ez-5zS_vre2obb1BRwZRhEoUt9TTXLpEhExjiLWB5IyhWLlFKRltzTuOMluYqlCHKEM7nIRSZiL1RJHnERM3zvJbgccC8xhSJ67zuxKmYyrfr4JXUDHgwaMVTDG_rd1tnt7wymPUvNPA2Z7Z7XvwE_2tGqqS6flyfjbFme_CEk-b8M50243oBvslJHyy2Y08UCLK4UYlweTckLYumw9j_DAlxda0vhLcKb3WFZjYbl8bRmDhLLMajI6sHRz6_f7OEbBO5kWx7irU8QcBvK8UljWygyssXTPt2G_Qvp3h2YL8pC3wMS-zkVMkO8xUQgreZPGIYilp4vwjjJHHjZOkYqG3l2UyXkMG3TNDNDqZ0hB552tqNalOSvVkutf6XNwlSlFJd0U8o4CRx40j3G4TT_iUShy4mxQZRuVJeSc2xwKWfYCc4duFu7bNcUijmF0bFzIJpx5s7ASJrPPikOhlbanGPbIs9z4JX11XN6l_bXVz_Yq_v_YvwYruz2-um7zZ2tB3ANZyOuuddLMD8-nuiHiDDH2SMb2AQ-XrTr_wIT6YuR |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phosphorylation+alters+Bim-mediated+Mcl-1+stabilization+and+priming&rft.jtitle=The+FEBS+journal&rft.au=Conage-Pough%2C+Jason+E&rft.au=Boise%2C+Lawrence+H&rft.date=2018-07-01&rft.eissn=1742-4658&rft.volume=285&rft.issue=14&rft.spage=2626&rft_id=info:doi/10.1111%2Ffebs.14505&rft_id=info%3Apmid%2F29775995&rft.externalDocID=29775995 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-464X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-464X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-464X&client=summon |